Dr. Bryan D. Gescuk, MD

Dr. Gescuk practices at San Mateo Rheumatology Inc. in San Mateo, California.

Dr. Gescuk's NPI, 1295815579, was assigned on October 17, 2006. Dr. Gescuk graduated from Boston University School Of Medicine in 1996. Dr. Gescuk holds California license A65762.

Dr. Gescuk's primary practice is San Mateo Rheumatology Inc., at 101 S San Mateo Dr, San Mateo, CA 94401 in San Mateo County. The practice phone is (650) 348-6011.

Dr. Gescuk's primary practice is San Mateo Rheumatology Inc. in San Mateo, California. Dr. Gescuk is also affiliated with San Mateo Medical Center. The medical group on file is San Mateo Medical Center. Dmand AI also links Dr. Gescuk to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gescuk practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Gescuk's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Gescuk is board certified in internal medicine by the American Board of Internal Medicine. Dr. Gescuk is licensed in California.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, gout, joint arthropathy, joint cyst, joint pain and lupus among the conditions Dr. Gescuk treats.

CMS data shows 36,452 Medicare services from Dr. Gescuk across 15 procedure codes in 2024, for 374 Medicare patients. Medicare paid $801,492 for them. Every service was in an office.

CMS counts 374 Medicare patients who saw Dr. Gescuk in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have arthritis, and 72% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gescuk's median patient age at 69, with 68% women.

In 2024, Dr. Gescuk wrote 2,550 Medicare Part D claims for 439 patients. 77% of them were for generic drugs. CMS names the drug for 2,208 of them, across 45 drugs with 11 or more claims each, at $3,646,168 in total drug cost. In 2023, CMS named 1,641 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Gescuk for performance year 2024, reported as part of a group. Dr. Gescuk accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gescuk as offering telehealth.

Dmand AI links 4 papers to Dr. Gescuk. The most frequent topics are Avoidance Learning, Electroshock and Morphine. Dr. Gescuk has published most often in Brain Res.

CMS Open Payments shows 1,611 general payments to Dr. Gescuk from 34 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Abbvie Inc. paid the most, $285,708.

Dr. Gescuk graduated from Boston University School Of Medicine in 1996.

Dr. Gescuk is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.